Form 4 for MRNA Moderna
Accepted 2022-11-30 00:00:00 ET · period of report 2022-11-28 · accession 0001127602-22-026544 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-30 | 2022-11-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $173.80 | -1,085 | 1.63M | -0.1% | -$188.6K |
| D | 2022-11-30 | 2022-11-28 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | +2,410 | 1.63M | +0.1% | $0 |
| D | 2022-11-30 | 2022-11-28 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -2,410 | 12.1K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-29 | S | D | 1,085 | $173.80 | 1,627,416 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-28 | M | A | 2,410 | $0.00 | 1,628,501 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-11-28 | M | D | 2,410 | $0.00 | 12,053 | D | $0.00 · 2022-02-28 to — | 2,410 Common Stock | (F4) 50% of the shares subject to this restricted stock unit award vested on February 28, 2022 with the remainder vesting in eight (8) equal quarterly installments thereafter. |